Affymetrix, eBioscience Remain in Talks over Proposed Acquisition | GenomeWeb

By Tony Fong

NEW YORK (GenomeWeb News) – Nearly two weeks after an exclusivity period expired, Affymetrix remains in talks to acquire eBioscience, a company official said today.

Doug Farrell, vice president of investor relations for Affymetrix, told GenomeWeb Daily News that although the exclusivity period for Affy lapsed at the end of the day on March 31, neither firm has canceled the acquisition agreement announced in November, and they remain in ongoing discussions regarding a deal.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: ancient Ethiopian genome indicates greater Eurasian backflow into Africa, sequencing to diagnose cutaneous T cell lymphoma, and more.

In Nature this week: genomic analysis of 200 bird species, and more.

The Australian High Court rules that isolated genetic material cannot be patented.

The startup incubator Y Combinator is launching a nonprofit research lab.